|
IRAK1BP1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.92369994880914E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.167730E-04 |
| Normal-vs-Stage2 |
3.659300E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
5.144800E-03 |
| Stage1-vs-Stage2 |
6.192800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
2.802400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.769400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.59699999949348E-07 |
| Normal-vs-AfricanAmerican |
6.6923999675339E-09 |
| Normal-vs-Asian |
5.134500E-02 |
| Caucasian-vs-AfricanAmerican |
3.450000E-01 |
| Caucasian-vs-Asian |
1.847560E-01 |
| AfricanAmerican-vs-Asian |
8.509600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.76639999999573E-05 |
| Normal-vs-Female |
4.41479999999661E-05 |
| Male-vs-Female |
7.735000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.499900E-03 |
| Normal-vs-Extreme_Weight |
1.257860E-03 |
| Normal-vs-Obese |
6.624200E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
7.375800E-01 |
| Normal_Weight-vs-Obese |
5.437200E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
3.826000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.154550E-01 |
| Normal-vs-Age(41-60Yrs) |
3.219800E-04 |
| Normal-vs-Age(61-80Yrs) |
7.76399999999899E-05 |
| Normal-vs-Age(81-100Yrs) |
5.343600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.278600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.845800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.639600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.123000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.737200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.535200E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.490200E-01 |
| Normal-vs-Grade 3 |
7.139200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.886800E-01 |
| Grade 2-vs-Grade 4 |
6.490200E-01 |
| Grade 3-vs-Grade 4 |
7.139200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.93300000004027E-06 |
| Normal-vs-N1 |
9.520100E-03 |
| N0-vs-N1 |
1.000760E-01 |
|
|
